Benzinga's Top #PreMarket Gainers
October 29, 2015 at 08:44 AM EDT
Revance Therapeutics Inc (NASDAQ: RVNC) shares surged 49.79 percent to $40.04 in pre-market trading after the company announced ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.